Insulet Reports Fourth Quarter 2018 Revenue of $164.9 Million, Up 26% Year-Over-Year, and Full Year 2018 Revenue of $563.8 Million, Up 22%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Broadcom rises 3% on OpenAI custom "Jalapeño" chip reveal
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Baird Reiterates Outperform on Insulet (PODD) Following 4Q
February 26, 2019 8:51 AM ESTBaird analyst, Jeff Johnson, reiterated an Outperform rating and $118.00 price target on Insulet Corporation (NASDAQ: PODD) following the company's 4Q earnings report. 4Q revenue of $165M exceeded consensus of $162M.
While 4Q results were solid, shares look likely to open lower as 2019... More
Insulet (PODD) Tops Q4 EPS by 9c, Revenues Beat; Offers Q1 Revenue Mid-Point Guidance Below Consensus, FY19 Revenue Views Below Consensus
February 25, 2019 4:03 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of $0.16, $0.09 better than the analyst estimate of $0.07. Revenue for the quarter came in at $164.8 million versus the consensus estimate of $162.46 million.
Fourth quarter 2018 revenue of $164.9 million, up 26% compared to $130.5 million in the prior year, exceeds guidance of $159 to $164 millionU.S. Omnipod revenue of $93.2 million, an increase of 22%International Omnipod revenue of... More